retatrutide expanded access compassionate use eli lilly Lilly's New Weight-Loss Treatment Shows Promising Results!! Retatrutide, designed to be taken once a week, met the primary endpoint in a phase 3 clinical. The initial TRIUMPH Phase 3 clinical development PolitiFact | A patient got

DRE (digital rectal exams) and PSA (prostate-specific antigen) blood tests, urine flow studies and in-depth prostate MRI or ultrasound scans may be used to assess BPH

Mahoney-Snchez, L

The researchers used electronic health record data from OneFlorida+ a health research network that includes 10 health systems and clinical partners that serve nearly 20 million patients in Florida, Georgia and Alabama to identify adults who were eligible for anti-obesity medications and had no cancer history

In this review, we will discuss currently available glucose-lowering treatments, and patient- and drug-specific factors to consider when selecting glucose-lowering therapy for the treatment of older adults ( 65 years of age) with T2D